Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health (HIMS), has filed 88 Form 4 transactions, all in the single company. The pattern is one-directional: zero open-market purchases and zero acquisitions of any kind, against $26.4 million in open-market sales. Every buy-side code in his history is mechanical, either option exercises (M), tax withholding (F), or compensation grants (A), none of which represent a discretionary investment.
The recent filings, all from 2026, show the same structure. On August 19, Oluyemi sold HIMS shares worth $148,111 after exercising options valued at $24,739. Two days earlier, on August 17, he sold $261,802 with a corresponding exercise of $47,033. The largest single sale in the recent window came on June 18, when he disposed of $1.94 million in stock. A June 22 sale added $619,216, and a July 6 sale brought $261,351. The August 14 filing included four option exercises valued at zero, paired with a tax withholding transaction of $1.03 million, which is automatic and not a market decision.
The seven most recent sell transactions, spanning May 18 through August 19, total roughly $3.6 million in open-market sales. The exercise prices on the paired M codes are small relative to the sale proceeds, which is typical for a CFO monetizing vested options. Oluyemi has not bought a single share on the open market across all 88 filings. The data shows consistent selling, with no purchases to offset it, and the pace has been steady through the summer months.
AI-assisted summary